• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估新的医疗价格透明度政策的影响。

Estimating the Impact of New Health Price Transparency Policies.

机构信息

University of Minnesota, Minneapolis, MN, USA.

出版信息

Inquiry. 2023 Jan-Dec;60:469580231155988. doi: 10.1177/00469580231155988.

DOI:10.1177/00469580231155988
PMID:36803142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9940230/
Abstract

This analysis investigates and scores the impact of new health price transparency rules. Using a set of novel data sources, we estimate substantial savings are possible following the implementation of the insurer price transparency rule. Specifically, we estimate annual savings to consumers, employers, and insurers by 2025, assuming a robust set of tools to allow consumers to purchase medical services. We matched claims with 70 HHS defined shoppable services by CPT and DRG codes and replaced them with an estimated median commercial allowed payment multiplied by a reduced cost of 40% based on estimates found from literature for the difference in cost between negotiated and cash payment for medical services. We consider 40% to be an upper bound estimate of the potential savings based on existing literature. Several databases are used to estimate the potential benefits of insurer price transparency. Two different all-payer claim databases were used, representing the entire insured population in the US. For this analysis, only the private insurer commercial population was examined, comprised of over 200 million covered lives as of 2021. The estimated impact of price transparency will vary significantly by region and income level. The national upper bound estimate is $80.7 billion. The national lower bound estimate is $17.6 billion. For the upper bound, the region with the most significant impact in the US will be the Midwest, with $20 billion in potential savings and an 8% reduction in medical expenditure. The region with the lowest impact will be the South, with only a 5.8% reduction. Concerning income, those at lower levels of income will have the most significant impact with a -7.4% (<100% Federal Poverty Level) to -7.5% (100%-137% Federal Poverty Level) impact. Overall, the total impact could be a 6.9% reduction for the whole privately insured population in the United States. In summary, a unique set of national data resources were used to estimate the cost savings impact medical price transparency. This analysis suggests price transparency for shoppable services may yields significant savings between $17.6 to $80.7 billion by 2025. Consumers may have strong incentives to shop with the rise in the use of high deductibles, health plans, and health savings accounts. How these potential saving are to be shared by consumers, employers and health plans has yet to be determined.

摘要

本分析研究并评估了新的医疗价格透明度规则的影响。使用一组新的数据源,我们估计在实施保险公司价格透明度规则后,可能会实现大量节省。具体来说,我们根据一系列允许消费者购买医疗服务的强大工具,估计了 2025 年消费者、雇主和保险公司的年度节省。我们将索赔与 HHS 定义的 70 项可购物服务进行匹配,并根据文献中发现的关于医疗服务协商支付和现金支付之间成本差异的估计,用估计的中位数商业可支付金额乘以 40%的降低成本进行替换。我们认为基于现有文献,40%是潜在节省的上限估计。使用了几个数据库来估计保险公司价格透明度的潜在收益。使用了两个不同的全支付者索赔数据库,代表美国的整个参保人群。在这项分析中,仅检查了私人保险公司商业人群,截至 2021 年,该人群覆盖了超过 2 亿人。价格透明度的估计影响将因地区和收入水平而异。全国上限估计为 807 亿美元。全国下限估计为 176 亿美元。对于上限,美国影响最大的地区将是中西部,潜在节省 200 亿美元,医疗支出减少 8%。影响最小的地区将是南部,仅减少 5.8%。关于收入,收入水平较低的人群受影响最大,降幅为-7.4%(低于联邦贫困线 100%)至-7.5%(联邦贫困线 100%-137%)。总体而言,美国整个私人保险人群的总影响可能降低 6.9%。总之,使用了一组独特的国家数据资源来估计医疗价格透明度的成本节约影响。这项分析表明,对于可购物服务的价格透明度,到 2025 年,可能会产生 176 亿至 807 亿美元的节省。随着高免赔额、健康计划和健康储蓄账户的使用增加,消费者可能会有强烈的购物动机。这些潜在的节省将如何在消费者、雇主和健康计划之间分配,还有待确定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e683/9940230/7beb04fcc6f7/10.1177_00469580231155988-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e683/9940230/41dca7ac25a8/10.1177_00469580231155988-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e683/9940230/7beb04fcc6f7/10.1177_00469580231155988-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e683/9940230/41dca7ac25a8/10.1177_00469580231155988-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e683/9940230/7beb04fcc6f7/10.1177_00469580231155988-fig2.jpg

相似文献

1
Estimating the Impact of New Health Price Transparency Policies.评估新的医疗价格透明度政策的影响。
Inquiry. 2023 Jan-Dec;60:469580231155988. doi: 10.1177/00469580231155988.
2
The impact of price transparency on consumers and providers: A scoping review.价格透明度对消费者和提供者的影响:范围综述。
Health Policy. 2020 Aug;124(8):819-825. doi: 10.1016/j.healthpol.2020.06.001. Epub 2020 Jun 5.
3
Playing by the Rules? Tracking U.S. Hospitals' Responses to Federal Price Transparency Regulation.遵守规则?追踪美国医院对联邦价格透明度法规的回应。
J Healthc Manag. 2024;69(1):45-58. doi: 10.1097/JHM-D-23-00014.
4
Do Insurers With Greater Market Power Negotiate Consistently Lower Prices for Hospital Care? Evidence From Hospital Price Transparency Data.保险公司的市场势力越大,是否会一直协商降低医院护理的价格?来自医院价格透明度数据的证据。
Med Care Res Rev. 2024 Feb;81(1):78-84. doi: 10.1177/10775587231193475. Epub 2023 Aug 18.
5
The Secret Menu in Health Care: A Cash Market for Imaging in California.医疗保健的秘密菜单:加利福尼亚的影像现金市场。
Inquiry. 2020 Jan-Dec;57:46958020981449. doi: 10.1177/0046958020981449.
6
Less Than One-third of Hospitals Provide Compliant Price Transparency Information for Total Joint Arthroplasty Procedures.不到三分之一的医院提供符合要求的全膝关节置换术价格透明度信息。
Clin Orthop Relat Res. 2022 Dec 1;480(12):2316-2326. doi: 10.1097/CORR.0000000000002288. Epub 2022 Jun 24.
7
Price Transparency in Radiology-A Model for the Future.放射科的价格透明度——未来的模式。
J Am Coll Radiol. 2020 Jan;17(1 Pt B):194-199. doi: 10.1016/j.jacr.2019.08.011.
8
Offering A Price Transparency Tool Did Not Reduce Overall Spending Among California Public Employees And Retirees.提供价格透明度工具并未降低加利福尼亚州公共雇员和退休人员的总体支出。
Health Aff (Millwood). 2017 Aug 1;36(8):1401-1407. doi: 10.1377/hlthaff.2016.1636.
9
Barriers to Price and Quality Transparency in Health Care Markets.医疗保健市场中价格与质量透明度的障碍。
Rand Health Q. 2022 Jun 30;9(3):1. eCollection 2022 Jun.
10
Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US.美国商业保险患者基于医院护理的公开医院价格与总报销的一致性。
JAMA Netw Open. 2021 Dec 1;4(12):e2137390. doi: 10.1001/jamanetworkopen.2021.37390.

引用本文的文献

1
Gender-Affirming Surgery Price Transparency and Online Information Availability in US Hospitals.美国医院性别肯定手术的价格透明度和在线信息可及性
Aesthetic Plast Surg. 2025 Jun 24. doi: 10.1007/s00266-025-05017-1.
2
Hospitals with decreasing cost-to-charge ratios bill greater surgical charges for similar outcomes.成本与收费比降低的医院对类似的治疗结果收取更高的手术费用。
Surgery. 2024 Oct;176(4):1123-1130. doi: 10.1016/j.surg.2024.06.018. Epub 2024 Jul 14.
3
Counting the Cost of Pins and Needles: A Case Study of Paresthesias and the Cost of Healthcare in the United States.

本文引用的文献

1
Patterns of Use of a Price Transparency Tool for Childbirth Among Pregnant Individuals With Commercial Insurance.商业保险孕妇使用分娩价格透明工具的模式。
JAMA Netw Open. 2021 Aug 2;4(8):e2121410. doi: 10.1001/jamanetworkopen.2021.21410.
2
Paying patients to use lower-priced providers.付费让患者选择价格较低的医疗机构。
Health Serv Res. 2022 Feb;57(1):37-46. doi: 10.1111/1475-6773.13711. Epub 2021 Aug 9.
3
Taking the Pulse of Hospitals' Response to the New Price Transparency Rule.把脉医院对新价格透明度规则的应对情况。
计算刺痛感的代价:美国感觉异常及医疗保健成本的案例研究。
Cureus. 2024 Apr 29;16(4):e59302. doi: 10.7759/cureus.59302. eCollection 2024 Apr.
4
Price Transparency in United States' Health Care: A Narrative Policy Review of the Current State and Way Forward.美国医疗保健中的价格透明度:当前状况与未来发展的叙述性政策回顾。
Inquiry. 2024 Jan-Dec;61:469580241255823. doi: 10.1177/00469580241255823.
5
Tennessee hospital noncompliance with price transparency legislation for 8 common laboratory tests.田纳西州的医院未遵守 8 项常见实验室检测的价格透明度法规。
Am J Clin Pathol. 2024 Nov 4;162(5):450-454. doi: 10.1093/ajcp/aqae057.
6
Oncologic Surgery in the United States: Do You Get What You Pay For?美国的肿瘤外科手术:物有所值吗?
Ann Surg Oncol. 2024 Jul;31(7):4167-4168. doi: 10.1245/s10434-024-15298-6. Epub 2024 Apr 22.
7
Cloudiness in price transparency for hernia repair.疝气修补价格透明度方面的模糊性。
Am J Surg. 2023 Nov;226(5):609. doi: 10.1016/j.amjsurg.2023.09.003. Epub 2023 Sep 4.
Med Care Res Rev. 2022 Jun;79(3):428-434. doi: 10.1177/10775587211024786. Epub 2021 Jun 19.
4
Online Advertising Increased New Hampshire Residents' Use Of Provider Price Tool But Not Use Of Lower-Price Providers.在线广告增加了新罕布什尔州居民使用供应商价格工具的频率,但并未增加他们选择低价供应商的频率。
Health Aff (Millwood). 2021 Mar;40(3):521-528. doi: 10.1377/hlthaff.2020.01039.
5
THE PRICE AIN'T RIGHT? HOSPITAL PRICES AND HEALTH SPENDING ON THE PRIVATELY INSURED.价格不合理?医院价格与私人保险人群的医疗支出
Q J Econ. 2019 Feb;134(1):51-107. doi: 10.1093/qje/qjy020. Epub 2018 Sep 4.
6
Price Transparency in Health Care Has Been Disappointing, but It Doesn't Have to Be.医疗保健领域的价格透明度一直令人失望,但并非必然如此。
JAMA. 2019 Oct 1;322(13):1243-1244. doi: 10.1001/jama.2019.14603.
7
Offering A Price Transparency Tool Did Not Reduce Overall Spending Among California Public Employees And Retirees.提供价格透明度工具并未降低加利福尼亚州公共雇员和退休人员的总体支出。
Health Aff (Millwood). 2017 Aug 1;36(8):1401-1407. doi: 10.1377/hlthaff.2016.1636.
8
Association between availability of health service prices and payments for these services.卫生服务价格的可及性与这些服务的支付之间的关联。
JAMA. 2014;312(16):1670-6. doi: 10.1001/jama.2014.13373.
9
Increases in consumer cost sharing redirect patient volumes and reduce hospital prices for orthopedic surgery.消费者分担成本的增加会改变患者的流量,并降低骨科手术的医院价格。
Health Aff (Millwood). 2013 Aug;32(8):1392-7. doi: 10.1377/hlthaff.2013.0188.